RESUMEN
ABSTRACT: The second of a two-part series, this article describes eight recently approved drugs, including the first drug approved for the treatment of SARS-CoV-2, a first-in-class HIV attachment inhibitor, and a new intravenous injection indicated for the treatment of acute pain in adults for whom other treatments are ineffective.
Asunto(s)
Aprobación de Drogas , Adenosina Monofosfato/análogos & derivados , Adenosina Monofosfato/uso terapéutico , Alanina/análogos & derivados , Alanina/uso terapéutico , Amisulprida/uso terapéutico , Carbamatos/uso terapéutico , Cefalosporinas/uso terapéutico , Clorofenoles/uso terapéutico , Combinación de Medicamentos , Fumaratos/uso terapéutico , Humanos , Indanos/uso terapéutico , Organofosfatos/uso terapéutico , Oxadiazoles/uso terapéutico , Piperazinas/uso terapéutico , Compuestos de Espiro/uso terapéutico , Tetrazoles/uso terapéutico , Tiofenos/uso terapéutico , Trometamina/uso terapéutico , Estados Unidos , United States Food and Drug Administration , Tratamiento Farmacológico de COVID-19 , CefiderocolRESUMEN
ABSTRACT: This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Anticuerpos Monoclonales Humanizados/uso terapéutico , Benzamidas/uso terapéutico , Ácidos Dicarboxílicos/uso terapéutico , Ácidos Grasos/uso terapéutico , Compuestos Heterocíclicos de 4 o más Anillos/uso terapéutico , Humanos , Piperidinas/uso terapéutico , Piridinas/uso terapéutico , Pirimidinas/uso terapéutico , Pirroles/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Amifampridina/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Azetidinas/uso terapéutico , Compuestos de Bencilo/uso terapéutico , Diterpenos/uso terapéutico , Compuestos Heterocíclicos con 3 Anillos/uso terapéutico , Humanos , Péptidos Cíclicos/uso terapéutico , Compuestos Policíclicos/uso terapéutico , Rifamicinas/uso terapéutico , Tioglicolatos/uso terapéutico , Estados Unidos , United States Food and Drug Administration , alfa-MSH/uso terapéuticoRESUMEN
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Anticuerpos Monoclonales/uso terapéutico , Benzofuranos/uso terapéutico , Carbamatos/uso terapéutico , Humanos , Fenilalanina/análogos & derivados , Fenilalanina/uso terapéutico , Piperidinas/uso terapéutico , Purinas/uso terapéutico , Tetraciclinas/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
This article reviews eight drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Aminofenoles/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Compuestos de Azabiciclo/uso terapéutico , Benzodioxoles/uso terapéutico , Cilastatina/uso terapéutico , Combinación de Medicamentos , Etinilestradiol/uso terapéutico , Vectores Genéticos/uso terapéutico , Humanos , Imipenem/uso terapéutico , Indoles/uso terapéutico , Nitroimidazoles/uso terapéutico , Pregnanolona/uso terapéutico , Pregnenodionas/uso terapéutico , Pirazoles/uso terapéutico , Piridinas/uso terapéutico , Pirrolidinas/uso terapéutico , Quinolonas/uso terapéutico , Retinoides/uso terapéutico , Estados Unidos , United States Food and Drug Administration , beta-Ciclodextrinas/uso terapéuticoRESUMEN
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Aminoquinolinas/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Benzamidas/uso terapéutico , Cannabidiol/uso terapéutico , Carbamatos/uso terapéutico , Dibenzotiepinas , Humanos , Morfolinas , Oxazinas/uso terapéutico , Piridinas/uso terapéutico , Piridonas , Tiepinas/uso terapéutico , Triazinas/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
This article reviews eight drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Amidas , Angiotensina II/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Azetidinas/uso terapéutico , Clonidina/análogos & derivados , Clonidina/uso terapéutico , Compuestos Heterocíclicos con 3 Anillos , Compuestos Heterocíclicos de 4 o más Anillos/uso terapéutico , Humanos , Hidrocarburos Fluorados/uso terapéutico , Piperazinas , Purinas , Pirazoles , Piridonas , Pirimidinas/uso terapéutico , Silicatos/uso terapéutico , Sulfonamidas/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
This article reviews nine drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Aminopiridinas , Cinamatos/uso terapéutico , Factor Xa/uso terapéutico , Humanos , Macrólidos/uso terapéutico , Morfolinas , Oligonucleótidos/uso terapéutico , Oxazinas/uso terapéutico , Piridinas/uso terapéutico , Pirimidinas , ARN Interferente Pequeño/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Sisomicina/análogos & derivados , Sisomicina/uso terapéutico , Tetraciclinas/uso terapéutico , Tiazoles/uso terapéutico , Tiofenos/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Asunto(s)
Aprobación de Drogas , Aminofenoles/uso terapéutico , Aminopiridinas/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Benzoatos/uso terapéutico , Benzodioxoles/uso terapéutico , Compuestos Bicíclicos Heterocíclicos con Puentes/uso terapéutico , Combinación de Medicamentos , Péptidos Similares al Glucagón/uso terapéutico , Humanos , Indoles/uso terapéutico , Quinolonas/uso terapéutico , Estados Unidos , United States Food and Drug Administration , beta-Alanina/análogos & derivados , beta-Alanina/uso terapéutico , cis-trans-Isomerasas/uso terapéuticoRESUMEN
This article discusses eight drugs recently approved by the FDA, including their indications and contraindications, precautions, dosage, and nursing considerations. The article also includes summary charts on 14 recently approved antineoplastic drugs and four drugs approved for rare disorders.
Asunto(s)
Aprobación de Drogas , Acetatos/uso terapéutico , Ácidos Borónicos/uso terapéutico , Combinación de Medicamentos , Fluoroquinolonas/uso terapéutico , Humanos , Meropenem , Metronidazol/análogos & derivados , Metronidazol/uso terapéutico , Nitroimidazoles/uso terapéutico , Proteína Relacionada con la Hormona Paratiroidea/uso terapéutico , Péptidos/uso terapéutico , Prostaglandinas F Sintéticas/uso terapéutico , Quinazolinas/uso terapéutico , Tienamicinas/uso terapéutico , Estados Unidos , United States Food and Drug AdministrationRESUMEN
Five new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include an anticoagulant, an antiparkinson agent, an agent for tardive dyskinesia, an agent for psoriasis, and an agent for constipation. The drugs reviewed are betrixaban, safinamide mesylate, valbenazine tosylate, guselkumab, and plecanatide.
Asunto(s)
Aprobación de Drogas , Anciano , Alanina/análogos & derivados , Alanina/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Anticoagulantes/uso terapéutico , Antiparkinsonianos/uso terapéutico , Benzamidas/uso terapéutico , Bencilaminas/uso terapéutico , Estreñimiento/tratamiento farmacológico , Humanos , Péptidos Natriuréticos/uso terapéutico , Psoriasis/tratamiento farmacológico , Piridinas/uso terapéutico , Discinesia Tardía/tratamiento farmacológico , Tetrabenazina/análogos & derivados , Tetrabenazina/uso terapéutico , Valina/análogos & derivados , Valina/uso terapéuticoRESUMEN
Five new drugs marketed within the last year that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, an agent for gout, an antipsychotic agent, and a drug for dry eye disease.
Asunto(s)
Antiinflamatorios/uso terapéutico , Antipsicóticos/uso terapéutico , Drogas en Investigación/uso terapéutico , Supresores de la Gota/uso terapéutico , Hipoglucemiantes/uso terapéutico , Antiinflamatorios/efectos adversos , Antipsicóticos/efectos adversos , Drogas en Investigación/efectos adversos , Síndromes de Ojo Seco/tratamiento farmacológico , Supresores de la Gota/efectos adversos , Humanos , Hipoglucemiantes/efectos adversos , Insulina de Acción Prolongada/uso terapéutico , Péptidos/uso terapéutico , Fenilalanina/análogos & derivados , Fenilalanina/uso terapéutico , Piperidinas/uso terapéutico , Sulfonas/uso terapéutico , Tioglicolatos/uso terapéutico , Triazoles/uso terapéutico , Urea/análogos & derivados , Urea/uso terapéuticoRESUMEN
Six new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include a hypnotic, an anticoagulant, two drugs for heart failure, and two drugs to reduce low-density lipoprotein cholesterol.
Asunto(s)
Anticolesterolemiantes/uso terapéutico , Anticoagulantes/uso terapéutico , Insuficiencia Cardíaca/tratamiento farmacológico , Hipnóticos y Sedantes/uso terapéutico , Anciano , Aprobación de Drogas , Humanos , Estados UnidosAsunto(s)
Sodio , Aminofenoles , Compuestos de Azabiciclo , Benzodioxoles , Combinación Cilastatina e Imipenem , Humanos , Indoles , Nitroimidazoles , Pirazoles , Piridinas , Pirrolidinas , QuinolonasRESUMEN
Six new drugs approved within the last two years, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, one bronchodilator, one antidepressant, one for erectile dysfunction, and one for menopause-associated conditions.